Krystal Biotech Inc (KRYS)

164.75 +3.92 (+2.44%) USD  |  NASDAQ  |  Dec 20, 16:00
165.06 +0.31 (+0.19%) After-Hours: 20:00
More

Krystal Biotech Max Drawdown (5Y): 53.42% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Bioventus Inc --
ADMA Biologics Inc 84.77%
Alnylam Pharmaceuticals Inc 42.46%
Amicus Therapeutics Inc 74.97%
Insmed Inc 63.30%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) 15.35
Beta (5Y) 0.7988
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 57.77%
Historical Sharpe Ratio (5Y) 0.4503
Historical Sortino (5Y) 1.004
Monthly Value at Risk (VaR) 5% (5Y Lookback) 19.30%